Cargando…

Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19

COVID-19 disease caused by the SARS-CoV-2 virus is characterized by dysregulation of effector T cells and accumulation of exhausted T cells. T cell responses to viruses can be corrected by adoptive cellular therapy using donor-derived virus-specific T cells. One approach is the establishment of bank...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Rachel S., Fraser, Alasdair R., Smith, Linda, Burgoyne, Paul, Imlach, Stuart N., Jarvis, Lisa M., Turner, David M., Zahra, Sharon, Turner, Marc L., Campbell, John D. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819874/ https://www.ncbi.nlm.nih.gov/pubmed/33488592 http://dx.doi.org/10.3389/fimmu.2020.598402

Ejemplares similares

Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis
por: Fraser, Alasdair R., et al.
Publicado: (2017)

GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC
por: Fekete, Natalie, et al.
Publicado: (2012)

GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
por: Haack-Sørensen, Mandana, et al.
Publicado: (2022)

An Approach towards a GMP Compliant In-Vitro Expansion of Human Adipose Stem Cells for Autologous Therapies
por: Jossen, Valentin, et al.
Publicado: (2020)

Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells
por: Tischer, Sabine, et al.
Publicado: (2014)

Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy
por: Seay, Howard R., et al.
Publicado: (2016)

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
por: Lim, Okjae, et al.
Publicado: (2013)

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
por: Vickers, Mark A, et al.
Publicado: (2014)

Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011)

Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects “stemness” properties
por: Bakopoulou, Athina, et al.
Publicado: (2017)

Expression of CD146 and Regenerative Cytokines by Human Placenta-Derived Mesenchymal Stromal Cells upon Expansion in Different GMP-Compliant Media
por: Peissert, Frederik, et al.
Publicado: (2021)

Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells
por: Jabbarpour, Zahra, et al.
Publicado: (2022)

Next generation automated traceless cell chromatography platform for GMP-compliant cell isolation and activation
por: Radisch, Sabine, et al.
Publicado: (2022)

Standardized GMP-compliant scalable production of human pancreas organoids
por: Dossena, Marta, et al.
Publicado: (2020)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

(1)H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures
por: Agostini, Francesco, et al.
Publicado: (2018)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor
por: Fitzgerald, Joan C., et al.
Publicado: (2022)

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform
por: Patel, Shabnum, et al.
Publicado: (2019)

Evaluation of Tissue Homogenization to Support the Generation of GMP-Compliant Mesenchymal Stromal Cells from the Umbilical Cord
por: Emnett, Ryan J., et al.
Publicado: (2016)

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)

GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
por: Tait, Angela, et al.
Publicado: (2021)

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18
por: Glienke, Wolfgang, et al.
Publicado: (2022)

Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBV‐specific T cell therapy
por: Cooper, Rachel S., et al.
Publicado: (2021)

A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
por: Fraser, Henrieta, et al.
Publicado: (2018)

Lentivirus-induced ‘Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
por: Sundarasetty, B S, et al.
Publicado: (2015)

Creation of GMP-Compliant iPSCs From Banked Umbilical Cord Blood
por: Tian, Pei, et al.
Publicado: (2022)

Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells
por: Shafa, Mehdi, et al.
Publicado: (2019)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo
por: Asperti, Claudia, et al.
Publicado: (2023)

Process data of allogeneic ex vivo-expanded ABCB5(+) mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
por: Ballikaya, Seda, et al.
Publicado: (2020)

Fully Automated GMP-Compliant Synthesis of [(18)F]FE-PE2I
por: Bratteby, Klas, et al.
Publicado: (2021)

Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2022)

T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients
por: Klaver, Yarne, et al.
Publicado: (2016)

Abstract 18 Leveraging the BMDI Cord Blood Bank to Create a GMP-Compliant Cord Blood (CB)–Derived Induced Pluripotent Stem Cell (iPSC) Master Cell Bank (MCB) for Potential Allogeneic Therapies
por: Tian, Pei, et al.
Publicado: (2023)

Improved GMP-compliant multi-dose production and quality control of 6-[(18)F]fluoro-L-DOPA
por: Luurtsema, G., et al.
Publicado: (2016)

Optimised GMP-compliant production of [(18)F]DPA-714 on the Trasis AllinOne module
por: Cybulska, Klaudia A., et al.
Publicado: (2021)

A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product
por: Born, Stephan, et al.
Publicado: (2019)

GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System
por: Tirughana, Revathiswari, et al.
Publicado: (2018)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vhtc5d6baa7opmhs4qlend7jnh